Morehead City, North Carolina Clinical Trials

A listing of Morehead City, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36 clinical trials
A Randomized Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH

A randomized, double-blind study to assess the safety and efficacy of EDP-305 in subjects with liver-biopsy proven Non-Alcoholic Steatohepatitis (NASH)

steatosis
fibrosis
vasectomy
fatty liver
body mass index
Lucas Research
 (1.1 away) Contact site
  • 50 views
  • 18 Jun, 2021
  • +85 other locations
Efficacy Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Randomized, double-blind, parallel-group, multicenter study to assess efficacy, safety, and tolerability of oral tropifexor & licogliflozin combination therapy and each monotherapy, compared with placebo for treatment of adult patients with nonalcoholic steatohepatitis (NASH) and liver fibrosis

Novartis Investigative Site
 (204.6 away) Contact site
  • 24 views
  • 20 Jun, 2021
  • +92 other locations
A Study to Assess Safety Tolerability PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients

This study is intended to investigate the safety and tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of AZD2693, following subcutaneous (SC) administration of multiple ascending doses in participants with Non-alcoholic Steatohepatitis (NASH) with fibrosis Stage 0 to 3 and homozygous for the patatin-like phospholipase domain-containing 3 (PNPLA3) 148M risk allele.

Research Site
 (1.5 away) Contact site
  • 0 views
  • 12 Jun, 2021
  • +13 other locations
Study of ARO-ANG3 in Adults With Mixed Dyslipidemia

The purpose of AROANG3-2001 is to evaluate the efficacy and safety of ARO-ANG3 in participants with mixed dyslipidemia. Participants will receive 2 subcutaneous injections of ARO-ANG3 or placebo.

Research Site
 (1.5 away) Contact site
  • 0 views
  • 23 Jun, 2021
  • +1 other locations
Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)

The purpose of the study is to assess efficacy, safety and tolerability of treatment with zibotentan and dapagliflozin in combination and alone, compared with placebo in participants with chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) between 20 and 60 mL/min/1.73^2.

Research Site
 (1.5 away) Contact site
  • 0 views
  • 09 Jun, 2021
  • +148 other locations
ACTIV-2: A Study for Outpatients With COVID-19

Drug studies often look at the effect one or two drugs have on a medical condition, and involve one company. There is currently an urgent need for one study to efficiently test multiple drugs from more than one company, in people who have tested positive for COVID-19 but who do …

cough
pharyngitis
rhinorrhea
nausea
sore throat
Carteret Medical Group, LLC. (Site 1249), 302 Medical Park Ct.
 (1.1 away) Contact site
  • 104 views
  • 25 Jun, 2021
  • +217 other locations
A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.

This study is open to adults with type 2 diabetes who take metformin but still have too high blood sugar. The purpose of the study is to find the best dose of BI 456906 that reduces blood sugar. The study also looks at whether BI 456906 helps the participants lose …

metformin
glucagon
semaglutide
body mass index
Lucas Research, Inc.
 (1.1 away) Contact site
  • 127 views
  • 23 Jun, 2021
  • +97 other locations
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19. LY3819253 and LY3832479 will be given to participants with early symptoms of COVID-19. Samples will be taken from the back of the nose to determine how much virus is in …

cough
pharyngitis
sore throat
dyspnea
fever
East Carolina University
 (70.2 away) Contact site
  • 2399 views
  • 23 Jun, 2021
  • +206 other locations
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis

The present study D5272C00001 (Legacy # 3151-201-008) seeks to evaluate the efficacy and safety of brazikumab versus placebo in patients with moderately to severely active UC and will include assessments of clinical responses as demonstrated by improvement of symptoms and of colonic mucosal appearance as observed on endoscopy.

Research Site
 (1.5 away) Contact site
  • 0 views
  • 29 Jan, 2021
  • +67 other locations
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

This study is open to adults, aged 18 to 75 years, with overweight or obesity. People with body mass index (BMI) of 27 or higher to join the study. People who have diabetes cannot participate. The purpose of this study is to find out whether a medicine called BI 456906 …

overweight or obesity
diabetes
body mass index
PMG Research of Wilmington, LLC
 (75.8 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +32 other locations